Cargando…
Indication of Measures of Uncertainty for Statistical Significance in Abstracts of Published Oncology Trials: A Systematic Review and Meta-analysis
IMPORTANCE: There is growing consensus that reliance on P values, particularly a cutoff level of .05 for statistical significance, is a factor in the challenges in scientific reproducibility. Despite this consensus, publications describing clinical trial results with P values near .05 anecdotally us...
Autores principales: | Rubinstein, Samuel M., Sigworth, Elizabeth A., Etemad, Shervin, Martin, Richard L., Chen, Qingxia, Warner, Jeremy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991218/ https://www.ncbi.nlm.nih.gov/pubmed/31834396 http://dx.doi.org/10.1001/jamanetworkopen.2019.17530 |
Ejemplares similares
-
Development of a bayesian toxo-equivalence model between docetaxel and paclitaxel
por: Sigworth, Elizabeth A., et al.
Publicado: (2022) -
Scoping Review of Published Oncology Meta-analyses in High-Impact Oncology Journals
por: Haslam, Alyson, et al.
Publicado: (2023) -
Misleading Reporting (Spin) in Noninferiority Randomized Clinical Trials in Oncology With Statistically Not Significant Results: A Systematic Review
por: Ito, Chiyo, et al.
Publicado: (2021) -
Reporting of Statistical Inference in Abstracts of Major Cancer Journals, 1990 to 2020
por: Stang, Andreas, et al.
Publicado: (2022) -
Replacing statistical significance and non-significance with better approaches to sampling uncertainty
por: Hopkins, Will G.
Publicado: (2022)